MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

ResMed Inc

Затворен

СекторЗдравеопазване

213.27 -4.22

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

211.64

Максимум

222

Ключови измерители

By Trading Economics

Приходи

33M

345M

Продажби

62M

1.3B

P/E

Средно за сектора

26.46

63.778

EPS

2.43

Дивидентна доходност

0.95

Марж на печалбата

26.88

EBITDA

-79M

362M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+22.02% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.95%

2.39%

Следващи печалби

24.04.2025 г.

Следваща дата на дивидент

12.06.2025 г.

Следваща дата на екс-дивидент

7.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.9B

33B

Предишно отваряне

217.49

Предишно затваряне

213.27

Настроения в новините

By Acuity

49%

51%

178 / 386 Класиране в Healthcare

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.06.2024 г., 17:43 ч. UTC

Значими двигатели на пазара

Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update

7.11.2024 г., 03:53 ч. UTC

Пазарно говорене

U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk

25.10.2024 г., 09:10 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25.10.2024 г., 08:35 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

27.06.2024 г., 16:01 ч. UTC

Печалби

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

24.06.2024 г., 17:28 ч. UTC

Значими двигатели на пазара

ResMed, Inspire Medical Shares Down After Eli Lilly Provides Sleep Apnea Study Update

26.04.2024 г., 20:12 ч. UTC

Печалби

These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

26.04.2024 г., 20:09 ч. UTC

Печалби

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

26.04.2024 г., 14:01 ч. UTC

Печалби

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes -- IBD

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

22.02% нагоре

12-месечна прогноза

Среден 272.11 USD  22.02%

Висок 290 USD

Нисък 240 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

8

Купи

5

Задържане

0

Продай

Настроение

By Acuity

178 / 386 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.